about
Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasmaInvestigation of methods suitable for the matrix-assisted laser desorption/ionization mass spectrometric analysis of proteins from ribonucleoprotein complexes.High throughput proteome screening for biomarker detection.Top-down identification of endogenous peptides up to 9 kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry.Proteomic mass spectra classification using decision tree based ensemble methods.Proteomics for biodefense applications: progress and opportunities.MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.Mass spectrometry in diagnostic oncoproteomics.Molecular methods for the detection and characterization of Neisseria meningitidis.Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid.Proteomics in clinical trials and practice: present uses and future promise.Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.Serum peptidome profiling in patients with gastric cancer.Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.Direct antigen detection from immunoprecipitated beads using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; a new method for immunobeads-mass spectrometry (iMS).Proteomic profiling of pancreatic cancer for biomarker discovery.Phyloproteomics: what phylogenetic analysis reveals about serum proteomics.Pre-analytical stability of the plasma proteomes based on the storage temperature.The potential of proteomics for providing new insights into environmental impacts on human health.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Glycans and glycoproteins as specific biomarkers for cancer.Salivary peptidome profiling analysis for occurrence of new carious lesions in patients with severe early childhood caries.National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsQuantitative proteomics analysis of altered protein expression in the placental villous tissue of early pregnancy loss using isobaric tandem mass tags.Neutral desorption sampling of biological surfaces for rapid chemical characterization by extractive electrospray ionization mass spectrometry.RNA profiling of cell-free saliva using microarray technology.
P2860
Q30835879-E481E2F2-C7F5-44CE-8123-1EAF1BDCCBE2Q33202061-6294D5E8-EAD4-4E7C-BFC1-032EB127FD27Q33210641-C65F3BAD-98C0-439E-AB38-45259CBE11FFQ33211791-2F4D1307-CC04-4CAF-8460-4ED31BC723A2Q33214986-79F80EF1-2AA9-4728-ACF3-E1A69043AAF7Q33215043-530B69F5-9353-4191-A7F9-8A027C24116EQ33217610-75364B33-835F-4FC8-B017-B502B8AAA5CDQ33224210-AEF981DA-3A25-4ED6-91C1-DBE2C38B3B82Q33229676-10FC6C2F-BEB4-4D24-BFAA-D1D97B6B9E11Q33241392-90D0CE6A-E844-4ADE-8113-27B9582342A6Q33245305-8E636714-EC41-4629-B853-7AD3FA326C4EQ33328566-A8049FD3-81E8-4617-8D20-6688D4DEFFD5Q33955495-F8E7FA2C-259F-4E09-ADE7-26B60F9FCF54Q33962458-A266F32D-E5EC-420D-B15F-3FD6B860985EQ34077448-1A9FC961-8EF8-4982-A95E-6F5E148B26F3Q36026306-F70B7EEE-9EA1-445C-9271-B4814376EAA6Q36501871-732784D9-6AB4-45F2-9421-09ECD24461DFQ36858663-A0C3BA7C-8576-40C8-BB9A-C71411A6724DQ37031334-A5860A41-547D-4AF0-9C5A-3937914E6873Q37484011-F338499C-03AE-4316-AE98-38FFC9435DE4Q38945184-12E04AF6-DBF4-4984-B754-475202F50D77Q40496074-CA5D8459-BD85-4F40-B3B9-DA79AA3379ACQ41469418-3744CACA-52F2-486E-A9E8-5EDA3513FF9AQ42383930-DB68FD0F-DB8C-4FC1-8BD7-7D1DAC3DE295Q45296763-0C6FF6D3-CD34-4233-924C-6034F749766CQ46759712-A8239982-C4B9-4402-9477-010A22C9C6C4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mass spectrometry-based clinical proteomics.
@ast
Mass spectrometry-based clinical proteomics.
@en
type
label
Mass spectrometry-based clinical proteomics.
@ast
Mass spectrometry-based clinical proteomics.
@en
prefLabel
Mass spectrometry-based clinical proteomics.
@ast
Mass spectrometry-based clinical proteomics.
@en
P2093
P2860
P1433
P1476
Mass spectrometry-based clinical proteomics.
@en
P2093
Herbert Thiele
Mark T Flocco
Markus Kostrzewa
Sau-Mei Leung
Wolfgang Pusch
P2860
P304
P356
10.1517/PHGS.4.4.463.22753
P577
2003-07-01T00:00:00Z